Clinical Research Center of New England - Foxboro

Clinical Research Center of New England - Foxboro Advancing the development of new treatments and diagnostic tools for current and future patients.

Almost every successful treatment, therapy, and medical device is dependent upon the results of successful research studies, and patient participation in such studies is critical. The Neurology Center of New England conducts clinical trials with the goal of advancing the development of new treatments and diagnostic tools for our current and future patients. All of our trials take place here in the clinic located at 9 Payson Road Suite 100, Foxboro, MA.

If you've ever considered participating in a clinical research study, you may have heard the term IRB. Before a study ca...
09/02/2026

If you've ever considered participating in a clinical research study, you may have heard the term IRB.

Before a study can begin, the IRB carefully reviews the research plan to help ensure:

✔️ Participant safety is the top priority.
✔️ Risks are minimized whenever possible.
✔️ Participants receive clear, understandable information before deciding to join.
✔️ The study is conducted ethically and follows strict federal regulations.

The IRB continues to monitor research throughout the study, not just before it starts, helping ensure participants remain protected every step of the way.

You may be able to join if you: - Are 18 years or older- Have been diagnosed with gMG- Do not have any other autoimmune ...
08/31/2026

You may be able to join if you:

- Are 18 years or older
- Have been diagnosed with gMG
- Do not have any other autoimmune diseases, like rheumatoid arthritis or Sjögren’s syndrome.

We are inviting adults with MS to join the REMASTER Study, which is looking into an investigational study drug in a new ...
08/29/2026

We are inviting adults with MS to join the REMASTER Study, which is looking into an investigational study drug in a new class of disease-modifying therapies (DMTs).

No two Alzheimer's journeys are exactly alike.While memory loss is often the most recognized symptom, Alzheimer's diseas...
08/28/2026

No two Alzheimer's journeys are exactly alike.

While memory loss is often the most recognized symptom, Alzheimer's disease can affect each person differently. Some individuals may experience changes in thinking, problem-solving, communication, mood, or behavior before significant memory changes become noticeable.

Personalized care, early evaluation, and continued research are important. The more we learn about Alzheimer's disease, the better we can understand its many forms and work toward improved treatments for everyone affected.

Spasticity (muscle stiffness) can be one of the most challenging parts of multiple sclerosis (MS) to manage. Researchers...
08/27/2026

Spasticity (muscle stiffness) can be one of the most challenging parts of multiple sclerosis (MS) to manage. Researchers want to help-see if the BALANCE-MSS-1 Trial is right for you.

Something new is on the horizon for individuals recently diagnosed with Parkinson's disease.Our research team is prepari...
08/26/2026

Something new is on the horizon for individuals recently diagnosed with Parkinson's disease.

Our research team is preparing to launch a new clinical research study designed specifically for those in the early stages of their Parkinson's journey. If you or a loved one has been recently diagnosed, this may be an opportunity to contribute to research that could help shape the future of Parkinson's care.

Stay tuned for more details, including eligibility and enrollment information. We look forward to sharing more soon!

Strong sensitivity to certain medications may be an important sign to discuss with a healthcare provider.Our team is exp...
08/24/2026

Strong sensitivity to certain medications may be an important sign to discuss with a healthcare provider.

Our team is exploring a clinical research opportunity for individuals who may qualify for a Lewy Body Dementia study.

Learn more to see if you or someone you know may be eligible: neurocenterne.com/contact/ or call (781) 551-5812 opt. 4.

RESHAPE is a clinical trial looking at whether an investigational medicine with an alternative mechanism of action can h...
08/22/2026

RESHAPE is a clinical trial looking at whether an investigational medicine with an alternative mechanism of action can help people living with relapsing MS who are receiving treatment with ocrelizumab.

Talk to your doctor for more information about the RESHAPE study.

Address

18 Washington Street
Foxborough, MA
02035

Alerts

Be the first to know and let us send you an email when Clinical Research Center of New England - Foxboro posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share